aTyr Pharma (LIFE) Tops Q1 EPS by 3c

aTyr Pharma (NASDAQ: LIFE) reported Q1 EPS of ($0.29), $0.03 better than the analyst estimate of ($0.32).

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• DA Davidson Reiterates Neutral Rating on Fastenal (FAST), Says Would Buy on 'Any Meaningful Retrenchment'
• BMO Capital Reiterates Outperform Rating on HF Sinclair (DINO)